Genetically modified human umbilical cells could be a treatment for spinal cord injuries
Genetically modified human umbilical cord blood mononuclear cells have been shown to increase the number of Schwann cells in a murine model with spinal cord injuries. The results could lead to regenerative medicines for spinal cord injuries.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.